# Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

> **NCT03460873** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 432 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **PROCEDURE:** holmium laser enucleation of the prostate

## Key facts

- **NCT ID:** NCT03460873
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-11-07
- **Final completion:** 2019-11-28
- **Target enrollment:** 432 (ACTUAL)
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03460873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03460873, "Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03460873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*